First time in human (FTIH) and proof of concept (POC) studies of GSK2878175 (GSK175), a potent pan-genotypic non-nucleoside NS5B polymerase inhibitor of HCV replication

Authors
Category Primary study
ConferenceHepatology
Year 2014
This article has no abstract
Epistemonikos ID: 5c7f5bca273bcde718ae1f06644fc6a2166af005
First added on: Apr 30, 2026